- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Pralsetinib is a targeted drug used to treat specific RET fusion positive tumors. When using it, attention should be paid to multiple risks suc...
Cabozantinib is a multi-target tyrosine kinase inhibitor that requires strict monitoring of risks such as bleeding, thrombosis, and wound heali...
Cabozantinib is a multi-target tyrosine kinase inhibitor with broad-spectrum anti-cancer effects, known as the "panacea" of targeted drugs. Thi...
Cabozantinib is a multi-target tyrosine kinase inhibitor, and its side effects can be classified into severe reactions that require immediate m...
The side effects of Sotorasib can be divided into common reactions that can be self relieved and serious adverse reactions that require urgent ...
Sotorasib is a targeted therapy drug, and special attention should be paid to adverse reactions such as liver toxicity and interstitial lung di...
The standard dose of Sotorasib is 960mg orally per day, which needs to be adjusted in a stepwise manner according to adverse reactions. Specifi...
Sotorasib is an oral inhibitor targeting KRASG12C mutations, primarily used to treat non-small cell lung cancer and colorectal cancer with spec...
Sotorasib, as a KRASG12C mutation specific inhibitor, has shown significant efficacy in the treatment of non-small cell lung cancer and colorec...
Sotorasib has not yet been officially listed in Chinese Mainland. Patients need to obtain it through overseas channels, but they should pay att...
